3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
10
Multiple Myeloma
7
Glioma
6
Neoplasm Metastasis
5
Lymphoma
5
Hematologic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Neurofibromatosis 1
4
Pancreatic Neoplasms
3
Neoplasms
3
Colorectal Neoplasms
3
Thyroid Neoplasms
2
Neurofibroma, Plexiform
2
Lung Neoplasms
2
Leukemia, Myelomonocytic, Juvenile
2
Glioblastoma
2
Brain Neoplasms
2
Astrocytoma
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Sarcoma
1
Refractory Differentiated Thyroid Gland Carcinoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
12
Specimen Handling
11
Cisplatin
10
Platinum
8
1,2-diaminocyclohexaneplatinum II citrate
8
Radiotherapy, Intensity-Modulated
7
pembrolizumab
6
Carboplatin
6
Cetuximab
5
Radiation
4
Biopsy
4
(225)Ac-DOTA-c(RGDyK)
4
Taxes
3
Radiotherapy
3
Paclitaxel
3
Docetaxel
3
ipatasertib
2
cemiplimab
2
X-Rays
2
Interviews as Topic
2
Immunoglobulin G
2
Disulfides
2
toripalimab
1
peposertib
1
merphos
1
durvalumab
1
dehydroftorafur
1
cabozantinib
1
atezolizumab
1
Tretinoin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Laryngeal Neoplasms
×
trametinib
×
90 days
×
Clear all
No trials found.